GlassScriptPhysician profile
Kenneth B Graham
NPI 1457464778
$4,083.04
in general payments reported to CMS, 2019-2025
20 companies · $764 in 2025
The $764 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,644 · 2020: $14.62 · 2021: $104 · 2022: $336 · 2023: $555 · 2024: $665 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $1,127.36 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $511.14 | 2019-2025 | Eylea Hd, Eylea |
| Genentech USA, INC. | $478.31 | 2019-2025 | Vabysmo |
| Glaukos Corporation | $297.64 | 2019-2025 | Idosetr |
| Bausch & Lomb Americas INC. | $275.00 | 2024-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Abbvie INC. | $265.33 | 2022-2024 | |
| Apellis Pharmaceuticals, INC. | $245.70 | 2023-2024 | Syfovre |
| Coherus Oncology, INC. | $138.93 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $123.83 | 2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $122.11 | 2023 | Cequa |
| Aerie Pharmaceuticals, INC. | $119.24 | 2019 | |
| Alcon Vision LLC | $106.49 | 2022 | |
| Asd Specialty Healthcare, LLC | $104.50 | 2019 | |
| Allergan, INC. | $61.32 | 2019-2021 | |
| Mallinckrodt Enterprises LLC | $23.77 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.33 | 2021 | |
| Astellas Pharma US INC | $22.43 | 2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.35 | 2019 | |
| Biogen, INC. | $14.26 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Graham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.